Grimm W, Hoffmann J, Menz V, Luck K, Maisch B
Department of Cardiology, Hospital of the Philipps-University of Marburg, Germany.
J Am Coll Cardiol. 1998 Sep;32(3):739-45. doi: 10.1016/s0735-1097(98)00306-4.
This study investigated the role of programmed ventricular stimulation (PVS) for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy (IDC) and spontaneous nonsustained ventricular tachycardia (VT).
Nonsustained VT in patients with IDC has been associated with a high incidence of sudden cardiac death.
Over the course of 4 years, 34 patients with IDC, a left ventricular (LV) ejection fraction < or = 35%, and spontaneous nonsustained VT underwent PVS. All patients were prospectively followed for 24+/-13 months.
Sustained ventricular arrhythmias were induced in 13 patients (38%). Sustained monomorphic VT was induced in three patients (9%), and polymorphic VT or ventricular fibrillation (VF) in another 10 patients (29%). No sustained ventricular arrhythmia could be induced in 21 study patients (62%). Prophylactic implantation of third-generation defibrillators (ICDs) with electrogram storage capability was performed in all 13 patients with inducible sustained VT or VF, and in nine of 21 patients (43%) without inducible sustained VT or VF. There were no significant differences between the additional use of amiodarone, d,I-sotalol, and beta-blocker therapy during follow-up in patients with and without inducible VT or VF. During 24+/-13 months of follow-up, arrhythmic events were observed in nine patients (26%) including sudden cardiac deaths in two patients and ICD shocks for rapid VT or VF in seven patients. Arrhythmic events during follow-up occurred in four of 13 patients with inducible ventricular arrhythmias compared with five of 21 patients without inducible ventricular arrhythmias at PVS (31% vs. 24%, p=NS).
PVS does not appear to be helpful for arrhythmia risk stratification in patients with IDC, a left ventricular ejection fraction < or =35%, and spontaneous nonsustained VT. Due to the limited number of patients, however, the power of this study is too small to exclude moderately large differences in outcome between patients with IDC with and without inducible VT or VF.
本研究探讨程控心室刺激(PVS)在特发性扩张型心肌病(IDC)和自发性非持续性室性心动过速(VT)患者心律失常风险预测中的作用。
IDC患者的非持续性VT与心脏性猝死的高发生率相关。
在4年的时间里,34例左心室(LV)射血分数≤35%且有自发性非持续性VT的IDC患者接受了PVS。所有患者均进行了前瞻性随访,随访时间为24±13个月。
13例患者(38%)诱发出持续性室性心律失常。3例患者(9%)诱发出持续性单形性VT,另外10例患者(29%)诱发出多形性VT或心室颤动(VF)。21例研究患者(62%)未诱发出持续性室性心律失常。对所有13例诱发出持续性VT或VF的患者以及21例未诱发出持续性VT或VF患者中的9例(43%)进行了具有心电图存储功能的第三代除颤器(ICD)预防性植入。在随访期间,诱发出VT或VF的患者与未诱发出VT或VF的患者在胺碘酮、d,l-索他洛尔和β受体阻滞剂的额外使用方面无显著差异。在24±13个月的随访期间,9例患者(26%)发生了心律失常事件,包括2例心脏性猝死和7例因快速VT或VF接受ICD电击。在PVS时,13例诱发出室性心律失常的患者中有4例在随访期间发生心律失常事件,而21例未诱发出室性心律失常的患者中有5例发生心律失常事件(31%对24%,p=无显著性差异)。
对于左心室射血分数≤35%且有自发性非持续性VT的IDC患者,PVS似乎无助于心律失常风险分层。然而,由于患者数量有限,本研究的效能过小,无法排除诱发出VT或VF的IDC患者与未诱发出VT或VF的IDC患者在结局方面存在中度较大差异的可能性。